Associate Professor, Medicine, LSU School of Medicine New Orleans
Infectious Disease
Dr. Michael E. Hagensee, MD
|
|
Give Review
Michael Hagensee is an expert in the field of Infectious Disease. He attended Baylor College of Medicine. He received 2 awards: "Patient-Centered Medical Home Recognition Program" and "Super Doctor". Dr. Michael E. Hagensee is a published physician. He has 50 papers published. The most current publication "Cofactors with human papillomavirus in a population-based study of vulvar cancer." He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Modeling the impact of quadrivalent HPV vaccination on the incidence of Pap test abnormalities in the United States.
- Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk of subsequent infection in men.
- HPV 6/11, 16, 18 seroprevalence in men in two US cities.
- Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding.
- Oral HPV complications in HIV-infected patients.
- Human papillomavirus infection and disease in the HIV+ individual.
- The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositi...
- Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections.
- Vaginal swabs versus lavage for detection of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women.
- Prevalence of human papillomavirus genotypes in women from three clinical settings.
- Human papillomavirus infection and disease in HIV-infected individuals.
- Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals.
- Detection of human papillomavirus DNA in urine specimens from human immunodeficiency virus-positive women.
- Holoenzyme DNA polymerase III fixes mutations.
- HPV-1 capsids expressed in vitro detect human serum antibodies associated with foot warts.
- The association of current hormonal contraceptive use with type-specific HPV detection.
- Prevalence of high-risk HPV types and abnormal cervical cytology in American Indian/Alaska Native women, 2003-2005.
- Human papilloma virus infections and disease in HIV.
- A distinct cellular profile is seen in the human endocervix during Chlamydia trachomatis infection.
- Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005.
- A fish hook and liver disease: revisiting an old enemy.
- Seroepidemiology of low and high oncogenic risk types of human papillomavirus in a predominantly male cohort of STD clinic patients.
- Detection of cervical antibodies to human papillomavirus type 16 (HPV-16) capsid antigens in relation to detection of HPV-16 DNA and cervical lesions.
- Seroprevalence of human papillomavirus type 16 in pregnant women.
- Cofactors with human papillomavirus in a population-based study of vulvar cancer.
- Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men.
- The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
- Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins.
- Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids.
- Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a patient with GVHD after allogeneic BMT.
- Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992.
- Mycotic aortic aneurysm due to Yersinia enterocolitica.
- Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts.
- Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies.
- Hyperthyroidism induced by iodinated glycerol.
- Bleomycin-treated DNA is specifically cleaved only by endonuclease IV in E. coli.
- Repair response of Escherichia coli to hydrogen peroxide DNA damage.
- DNA polymerase III of Escherichia coli is required for UV and ethyl methanesulfonate mutagenesis.
- Multiple pathways for repair of hydrogen peroxide-induced DNA damage in Escherichia coli.
- DNA polymerase III requirement for repair of DNA damage caused by methyl methanesulfonate and hydrogen peroxide.
- Distribution of human papillomavirus type 16 variants in human immunodeficiency virus type 1-positive and -negative women.
- Optimization of PCR based detection of human papillomavirus DNA from urine specimens.
- Detection of human papillomavirus DNA in self-administered vaginal swabs as compared to cervical swabs.
- The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanisms.
- Lack of evidence for local immune activity in oral hairy leukoplakia and oral wart lesions.
- Knowledge of Pap screening and human papillomavirus among women attending clinics in MedellÃÂn, Colombia.
- Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States.
- Development and validation of a HPV-32 specific PCR assay.
- Comparative analysis of methods for collection and measurement of cytokines and immunoglobulins in cervical and vaginal secretions of HIV and HPV infected women.
Schools
Baylor University
University of Washington
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Amerihealth
- Blue Card PPO
- BlueConnect POS
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- WellCare
Awards
- Patient-Centered Medical Home Recognition Program
- Super Doctor
Education
-
University of Washington -
Baylor College of Medicine
Drug Facts
| NPI NUMBER | 1780603746 | |
| NPPES Provider LastName | HAGENSEE | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 701123095 | |
| NPPES Provider State | LA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 5432.0 | |
| Distinct Opioid Count | 7.0 | |
| Opioid Claim Count | 384.0 | |
| Percent Opioid Claims | 7.07 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1780603746 |
| Last Name Of The Provider | HAGENSEE |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Thomas A. Moore, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Obinna Nnedu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah N. Barbeau, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lee S. Engel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Newton E. Hyslop Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald J. Krogstad, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Rebecca A. Lillis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shiva Akula, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joseph R. Dalovisio, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joanne T. Maffei, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ceryl L. Besch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Morgan J. Katz, MD |
|
Dr. George A. Pankey, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Eric L. Mouzin, MD |
|
|
Dr. Holly A. Murphy, MD
This Doctor is OpenDoctor Recommended.
|